139 related articles for article (PubMed ID: 36700373)
1. Metabolites identification of anabolic steroid bolasterone in vitro and in rats by high resolution liquid chromatography mass spectrometry.
Muresan AR; Rahaman KA; Son J; Kang MJ; Kwon OS
Drug Test Anal; 2023; 15(11-12):1329-1343. PubMed ID: 36700373
[TBL] [Abstract][Full Text] [Related]
2. The use of in vitro technologies and high-resolution/accurate-mass LC-MS to screen for metabolites of 'designer' steroids in the equine.
Clarke A; Scarth J; Teale P; Pearce C; Hillyer L
Drug Test Anal; 2011 Jan; 3(1):74-87. PubMed ID: 21322180
[TBL] [Abstract][Full Text] [Related]
3. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
4. Metabolic studies of oxyguno in horses.
Wong AS; Ho EN; Wan TS; Lam KK; Stewart BD
Anal Chim Acta; 2015 Sep; 891():190-202. PubMed ID: 26388378
[TBL] [Abstract][Full Text] [Related]
5. Metabolic study of methylstenbolone in horses using liquid chromatography-high resolution mass spectrometry and gas chromatography-mass spectrometry.
Choi TLS; Wong JKY; Kwok WH; Curl P; Mechie S; Wan TSM
J Chromatogr A; 2018 Apr; 1546():106-118. PubMed ID: 29548567
[TBL] [Abstract][Full Text] [Related]
6. In vitro metabolism study of a black market product containing SARM LGD-4033.
Geldof L; Pozo OJ; Lootens L; Morthier W; Van Eenoo P; Deventer K
Drug Test Anal; 2017 Feb; 9(2):168-178. PubMed ID: 26767942
[TBL] [Abstract][Full Text] [Related]
7. Screening anabolic androgenic steroids in human urine: an application of the state-of-the-art gas chromatography-Orbitrap high-resolution mass spectrometry.
Ji Z; Liao L; Ge Y; Liu M; Fang X; Sun H; Zheng S; Deng X
Anal Bioanal Chem; 2024 May; 416(13):3223-3237. PubMed ID: 38573345
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo metabolism of the anabolic-androgenic steroid oxandrolone in the horse.
Harding C; Viljanto M; Cutler C; Habershon-Butcher J; Biddle S; Scarth J
Drug Test Anal; 2022 Jan; 14(1):39-55. PubMed ID: 34378336
[TBL] [Abstract][Full Text] [Related]
9. Gas chromatography properties and mass spectrometry fragmentation of anabolic androgenic steroids in doping control.
Zhang Y; He G; Sheng L; Zhao X; Zhang Y; Zhang Y; Xu Y; Lu J
Bioanalysis; 2023 Jun; 15(12):661-671. PubMed ID: 37431827
[No Abstract] [Full Text] [Related]
10. Liquid chromatography-mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes.
Kiousi P; Fragkaki AG; Kioukia-Fougia N; Angelis YS
Drug Test Anal; 2021 Nov; 13(11-12):1822-1834. PubMed ID: 33942526
[TBL] [Abstract][Full Text] [Related]
11. Detection of anabolic and androgenic steroids and/or their esters in horse hair using ultra-high performance liquid chromatography-high resolution mass spectrometry.
Kwok KY; Choi TLS; Kwok WH; Wong JKY; Wan TSM
J Chromatogr A; 2017 Apr; 1493():76-86. PubMed ID: 28314523
[TBL] [Abstract][Full Text] [Related]
12. Sulfate metabolites as alternative markers for the detection of 4-chlorometandienone misuse in doping control.
Balcells G; Gómez C; Garrostas L; Pozo ÓJ; Ventura R
Drug Test Anal; 2017 Jul; 9(7):983-993. PubMed ID: 27686240
[TBL] [Abstract][Full Text] [Related]
13. In vitro characterization of S-23 metabolites produced by human liver microsomes, and subsequent application to urine after a controlled oral administration.
Ameline A; Gheddar L; Raul JS; Kintz P
J Pharm Biomed Anal; 2022 Apr; 212():114660. PubMed ID: 35182830
[TBL] [Abstract][Full Text] [Related]
14. Metabolic study of androsta-1,4,6-triene-3,17-dione in horses using liquid chromatography/high resolution mass spectrometry.
Kwok WH; Leung GN; Wan TS; Curl P; Schiff PJ
J Steroid Biochem Mol Biol; 2015 Aug; 152():142-54. PubMed ID: 26031748
[TBL] [Abstract][Full Text] [Related]
15. Comparison of sulfo-conjugated and gluco-conjugated urinary metabolites for detection of methenolone misuse in doping control by LC-HRMS, GC-MS and GC-HRMS.
Fragkaki AG; Angelis YS; Kiousi P; Georgakopoulos CG; Lyris E
J Mass Spectrom; 2015 May; 50(5):740-8. PubMed ID: 26259657
[TBL] [Abstract][Full Text] [Related]
16. Enabling the inclusion of non-hydrolysed sulfated long term anabolic steroid metabolites in a screening for doping substances by means of gas chromatography quadrupole time-of-flight mass spectrometry.
Albertsdóttir AD; Van Gansbeke W; Van Eenoo P; Polet M
J Chromatogr A; 2021 Apr; 1642():462039. PubMed ID: 33735641
[TBL] [Abstract][Full Text] [Related]
17. Identification of metabolites of tectoridin in-vivo and in-vitro by liquid chromatography-tandem mass spectrometry.
Chen Y; Song W; Peng ZH; Ge BY; Han FM
J Pharm Pharmacol; 2008 Jun; 60(6):709-16. PubMed ID: 18498706
[TBL] [Abstract][Full Text] [Related]
18. New drostanolone metabolites in human urine by liquid chromatography time-of-flight tandem mass spectrometry and their application for doping control.
Liu Y; Lu J; Yang S; Zhang Q; Xu Y
Steroids; 2016 Apr; 108():61-7. PubMed ID: 26826321
[TBL] [Abstract][Full Text] [Related]
19. Elucidation of urinary metabolites of fluoxymesterone by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry.
Pozo OJ; Van Thuyne W; Deventer K; Van Eenoo P; Delbeke FT
J Mass Spectrom; 2008 Mar; 43(3):394-408. PubMed ID: 18035854
[TBL] [Abstract][Full Text] [Related]
20. In-depth gas chromatography/tandem mass spectrometry fragmentation analysis of formestane and evaluation of mass spectral discrimination of isomeric 3-keto-4-ene hydroxy steroids.
Kollmeier AS; de la Torre X; Müller C; Botrè F; Parr MK
Rapid Commun Mass Spectrom; 2020 Dec; 34(24):e8937. PubMed ID: 32876355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
